131 related articles for article (PubMed ID: 11183043)
1. Visual field defects associated with vigabratin monotherapy in children.
Luchetti A; Amadi A; Gobbi G
J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):566. PubMed ID: 11183043
[No Abstract] [Full Text] [Related]
2. Vigabatrin and epilepsy: further lessons in early childhood.
Parisi P; Bombardieri R; Curatolo P
Epilepsia; 2008 Jan; 49(1):177-8. PubMed ID: 18184225
[No Abstract] [Full Text] [Related]
3. Effects of antiepileptic drugs on visual function, with special reference to Vigabatrin.
Sorri I
Acta Ophthalmol Scand; 2002 Jun; 80(3):343-4. PubMed ID: 12059879
[No Abstract] [Full Text] [Related]
4. Visual field constriction on vigabatrin.
Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
[TBL] [Abstract][Full Text] [Related]
5. Vigabatrin: an antiepileptic drug with major benefits but significant adverse effects.
Besag FM
Curr Drug Saf; 2010 Jul; 5(3):188-90. PubMed ID: 20624131
[No Abstract] [Full Text] [Related]
6. [Visual field changes as a side effect of treatment with vigabatrin therapy].
Kobylański P
Neurol Neurochir Pol; 2000; 34(3):597-9. PubMed ID: 10979552
[No Abstract] [Full Text] [Related]
7. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):326-8. PubMed ID: 14746191
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin.
Lewis H; Wallace SJ
Dev Med Child Neurol; 2001 Dec; 43(12):833-5. PubMed ID: 11769271
[No Abstract] [Full Text] [Related]
9. Visual field constriction in 91 Finnish children treated with vigabatrin.
Vanhatalo S; Nousiainen I; Eriksson K; Rantala H; Vainionpää L; Mustonen K; Aärimaa T; Alen R; Aine MR; Byring R; Hirvasniemi A; Nuutila A; Walden T; Ritanen-Mohammed UM; Karttunen-Lewandowski P; Pohjola LM; Kaksonen S; Jurvelin P; Granström ML
Epilepsia; 2002 Jul; 43(7):748-56. PubMed ID: 12102679
[TBL] [Abstract][Full Text] [Related]
10. [Changes in visual field of a child treatment with vigabatrin for 2 years].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):313-4. PubMed ID: 14746187
[TBL] [Abstract][Full Text] [Related]
11. Are vigabatrin-associated visual field constrictions asymptomatic?
Schmidt T; Rüther K; Schmitz B
J Neurol; 2004 Jul; 251(7):887-8. PubMed ID: 15258797
[No Abstract] [Full Text] [Related]
12. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy.
Nousiainen I; Kälviäinen R; Mäntyjärvi M
Ophthalmology; 2000 May; 107(5):884-8. PubMed ID: 10811079
[TBL] [Abstract][Full Text] [Related]
13. No reversion in vigabatrin-associated visual field defects.
Nousiainen I; Mäntyjärvi M; Kälviäinen R
Neurology; 2001 Nov; 57(10):1916-7. PubMed ID: 11723291
[TBL] [Abstract][Full Text] [Related]
14. Epilepsy: Vigabatrin treatment and visual field loss.
Chiron C; Dulac O
Nat Rev Neurol; 2011 Apr; 7(4):189-90. PubMed ID: 21364521
[No Abstract] [Full Text] [Related]
15. Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero.
Sorri I; Herrgård E; Viinikainen K; Pääkkönen A; Heinonen S; Kälviäinen R
Epilepsy Res; 2005 Jun; 65(1-2):117-20. PubMed ID: 15941649
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological Evidences of Visual Field Alterations in Children Exposed to Vigabatrin Early in Life.
Hébert-Lalonde N; Carmant L; Major P; Roy MS; Lassonde M; Saint-Amour D
Pediatr Neurol; 2016 Jun; 59():47-53. PubMed ID: 27105764
[TBL] [Abstract][Full Text] [Related]
17. Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children.
Harding GF; Spencer EL; Wild JM; Conway M; Bohn RL
Neurology; 2002 Apr; 58(8):1261-5. PubMed ID: 11971096
[TBL] [Abstract][Full Text] [Related]
18. Is reduced ornithine-δ-aminotransferase activity the cause of vigabatrin-associated visual field defects?
Sorri I; Brigell MG; Mályusz M; Mahlamäki E; de Meynard C; Kälviäinen R
Epilepsy Res; 2010 Nov; 92(1):48-53. PubMed ID: 20850272
[TBL] [Abstract][Full Text] [Related]
19. Binasal visual field defects are not specific to vigabatrin.
Gonzalez P; Sills GJ; Parks S; Kelly K; Stephen LJ; Keating D; Dutton GN; Brodie MJ
Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
[TBL] [Abstract][Full Text] [Related]
20. Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin.
Werth R; Schädler G
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3028-35. PubMed ID: 16799049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
